Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,285.00p
   
  • Change Today:
    -45.00p
  • 52 Week High: 1,540.00
  • 52 Week Low: 910.00
  • Currency: UK Pounds
  • Shares Issued: 49.13m
  • Volume: 39,397
  • Market Cap: £631.35m
  • Beta: 0.57

Dividend Data

  31-Dec-2031-Dec-1931-Dec-1831-Dec-1731-Dec-16
Total Dividendn/an/an/an/an/a
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Continuing Operations          
Revenue 86.39 68.25 54.11 47.62 39.23
Operating Profit/(Loss) 13.53 5.52 (10.45) (3.90) 0.05
Net Interest (0.40) (0.24) (0.60) (0.55) (0.27)
Profit Before Tax 12.63 4.99 (10.77) (4.45) (0.22)
Profit After Tax 9.68 5.57 (8.98) (4.50) (0.07)
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 9.68 5.57 (8.98) (4.50) (0.07)
Attributable to:          
Equity Holders of Parent Company 9.68 5.57 (8.98) (4.50) (0.07)
Minority Interests n/a n/a n/a n/a n/a
           
Continuing EPS          
Earnings per Share - Basic 20.00p 12.00p (20.00p) (11.00p) (0.20p)
Earnings per Share - Diluted 19.20p 11.50p (20.00p) (11.00p) (0.20p)
Earnings per Share - Adjusted 25.80p 19.90p (20.00p) 4.20p 6.80p
Continuing and Discontinued EPS          
Earnings per Share - Basic 20.00p 12.00p (20.00p) (11.00p) (0.20p)
Earnings per Share - Diluted 19.20p 11.50p (20.00p) (11.00p) (0.20p)
Earnings per Share - Adjusted 25.80p 19.90p (20.00p) 4.20p 6.80p
           
Dividend per Share n/a n/a n/a n/a n/a
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Assets          
Non-Current Assets          
Property, Plant & Equipment 6.46 6.28 1.34 1.08 0.72
Intangible Assets 34.22 16.14 17.40 35.50 32.13
Investment Properties n/a n/a n/a n/a n/a
Investments n/a n/a 2.07 0.75 0.27
Other Financial Assets n/a n/a n/a n/a (0.01)
Other Non-Current Assets 4.90 2.62 0.58 1.61 1.45
  45.58 25.03 21.39 38.94 34.56
Current Assets          
Inventories n/a n/a n/a n/a n/a
Trade & Other Receivables 22.22 14.36 16.43 19.25 14.96
Cash at Bank & in Hand 18.99 14.26 5.19 3.22 4.42
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 5.55 3.38 3.86 0.50 0.24
  46.77 32.00 25.48 22.97 19.62
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 92.35 57.03 46.86 61.91 54.19
           
Liabilities          
Current Liabilities          
Borrowings 1.98 1.72 0.01 0.01 n/a
Other Current Liabilities 31.63 14.14 17.18 13.85 8.59
  33.61 15.86 17.19 13.86 8.59
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 3.13 3.72 n/a 0.01 0.01
Provisions 2.74 0.63 0.77 3.40 3.42
Other Non-Current Liabilities n/a n/a 0.54 9.80 7.77
  5.87 4.35 1.31 13.21 11.20
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 39.48 20.21 18,501.00 27.07 19.79
           
Net Assets 52.87 36.82 28.36 34.84 34.40
           
Capital & Reserves          
Share Capital 0.49 0.47 0.45 0.43 0.41
Share Premium Account n/a 25.79 24.38 20.62 17.96
Other Reserves 7.01 16.06 15.40 14.44 12.24
Retained Earnings 45.37 (5.51) (11.87) (0.64) 3.80
Shareholders Funds 52.87 36.82 28.36 34.84 34.40
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 52.87 36.82 28.36 34.84 34.40
Cash Flow 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Net Cash Flow From Operating Activities 18.05 11.79 2.10 0.07 (2.37)
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities (12.78) (2.83) (3.79) (3.92) (5.83)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities (0.48) (0.25) 3,774.00 2.68 8.65
Net Increase/Decrease In Cash 4.80 8.71 2.08 (1.16) 0.45
Ratios - based on IFRS 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Continuing Operations          
PE Ratio - Adjusted 40.9 19.7 n/a 43.7 22.4
PEG - Adjusted 1.4 n/a n/a n/a n/a
Earnings per Share Growth - Adjusted 30% n/a n/a -38% -28%
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 175.83p 138.92p 110.13p 96.93p 79.85p
Pre-Tax Profit per Share 25.70p 10.15p (21.92p) (9.05p) (0.45p)
Operating Margin 15.67% 8.08% (19.31%) (8.20%) 0.13%
Return on Capital Employed 49.16% 19.55% n/a n/a 0.88%
Continuing & Discontinued Operations          
PE Ratio - Adjusted 40.9 19.7 n/a 43.7 22.4
PEG - Adjusted 1.4 n/a n/a n/a n/a
Earnings per Share Growth - Adjusted 30% n/a n/a -38% -28%
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share 36.73p 23.99p 4.27p 0.14p (4.82p)
Cash Incr/Decr per Share 9.76p 17.72p 4.24p (2.37p) 0.92p
Net Asset Value per Share (exc. Intangibles) 37.95p 42.10p 22.32p (1.33p) 4.62p
Net Gearing -26.27% -23.97% -18.26% -9.18% -12.82%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page